ABOAGYE DUAH BOATEMAA (Ms.)

Masters of Public Health & Registered General Nurse

Definition of STDs and Infertility 

Sexually transmitted diseases (STDs) are infections caused by bacteria, viruses, or parasites, transmitted primarily through sexual contact with an infected individual. Common STDs such as Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis are known to significantly impact reproductive health (Zuo et al., 2023). Infertility, defined as the inability to conceive after 12 months of regular, unprotected intercourse, affects an estimated 15% of couples globally, with STDs contributing significantly to the burden (Hazlina et al., 2022). According to Kristensen et al. (2025), Chlamydia infections alone account for up to 20% of female infertility cases worldwide, while gonorrhea-related complications cause infertility in about 10% of infected individuals. These statistics emphasize the urgent need to address STDs as a key factor in reproductive health.

Pathophysiology: How STDs Lead to Infertility

STDs impair fertility through a variety of mechanisms. Infections such as Chlamydia and gonorrhea can cause pelvic inflammatory disease (PID), leading to scarring of the fallopian tubes and preventing egg-sperm interaction (Henkel et al., 2021). Chronic inflammation due to STDs alters the reproductive tract environment, affecting both gamete quality and embryo implantation. In men, infections compromise semen quality by reducing sperm motility, count, and morphology due to increased oxidative stress and leukocyte infiltration (Chen et al., 2023). Additionally, persistent infections can lead to epididymitis and testicular damage, further exacerbating infertility risks (Das et al., 2022). This underscores the role of early diagnosis and treatment in preventing irreversible reproductive damage.

Impacts of Common STDs (e.g., Chlamydia, Gonorrhea) on Fertility

Certain STDs are particularly detrimental to fertility.

• Chlamydia trachomatis: This bacterium is the leading cause of STD-related infertility. It is often asymptomatic, but untreated infections lead to PID in 10-15% of women, with tubal factor infertility occurring in about 20% of those cases (El-Kholi et al., 2021). In men, Chlamydia can reduce sperm quality and cause epididymitis (Khalafalla et al., 2023).
• Neisseria gonorrhoeae: Gonorrhea is another major contributor to infertility. It causes severe inflammation of the reproductive tract, resulting in tubal obstruction and ectopic pregnancy risks in women (Mbah et al., 2022). In men, gonorrhoea can cause epididymal blockages and impaired sperm function (Henkel et al., 2020).
• Trichomonas vaginalis: This parasitic infection is associated with increased risks of PID and adverse pregnancy outcomes, contributing indirectly to infertility. Women with recurrent Trichomonas infections are 2.5 times more likely to experience infertility compared to uninfected individuals (Hashemi & Soleimani, 2022).

The interplay of these infections highlights the critical need for routine screening and timely management to mitigate their reproductive health impacts.

Preventive Measures and Management of STD-Related Infertility

Preventing and managing STD-related infertility requires a multifaceted approach.

1. Education and Awareness: Public health campaigns to promote safe sexual practices, such as condom use, have proven effective in reducing STD transmission. Comprehensive sexual education in schools is essential for informing young adults about the risks of unprotected intercourse.
2. Screening and Early Diagnosis: Routine screening for high-risk groups, such as sexually active individuals under 25 years, is vital for early detection and treatment of asymptomatic infections. Advances in molecular diagnostics have improved the sensitivity and specificity of STD detection, allowing for prompt intervention (Rajabpour et al., 2020).
3. Treatment and Partner Management: Effective antibiotic regimens, such as azithromycin and ceftriaxone for Chlamydia and gonorrhoea, respectively, can eradicate infections and prevent complications. Partner notification and treatment are crucial to break the chain of transmission (Mathias et al., 2024).
4. Vaccination: Vaccines for certain STDs, such as the human papillomavirus (HPV), play a critical role in reducing the burden of infections that indirectly contribute to infertility (Tramontano et al., 2023).
5. Assisted Reproductive Technologies (ART): For individuals with STD-related infertility, ART, including in vitro fertilization (IVF), can offer a pathway to parenthood despite tubal damage or compromised semen quality (Buzzaccarini et al., 2020).

Conclusion

The relationship between STDs and infertility is well-established, with infections such as Chlamydia, gonorrhoea, and Trichomonas playing significant roles in reproductive dysfunction. These infections often go undiagnosed due to asymptomatic presentations, resulting in irreversible damage to the reproductive system. Preventive measures, including public education, routine screening, and effective treatment protocols, are essential to address this public health issue. Further research is needed to develop targeted interventions and improve access to reproductive health services, ensuring better outcomes for individuals affected by STD-related infertility.

References

Chen, J., Chen, J., Fang, Y., Shen, Q., Zhao, K., Liu, C., & Zhang, H. (2023). Microbiology and immune mechanisms associated with male infertility. Frontiers in Immunology, 14, 1139450.

Das, S., Roychoudhury, S., Roychoudhury, S., Agarwal, A., & Henkel, R. (2022). Role of infection and leukocytes in male infertility. In Oxidative Stress and Toxicity in Reproductive Biology and Medicine: A Comprehensive Update on Male Infertility-Volume One (pp. 115-140). Cham: Springer International Publishing.

El-Kholi, D. G., Hodeib, H. A., El-Bohoty, S. B., & Sharaf, M. A. (2021). Chlamydia trachomatis infection as a risk factor of infertility in women. Journal of Advances in Medicine and Medical Research, 33(9), 63-70.

Hashemi, N., & Soleimani, Z. (2022). The Relation Between Trichomonas Vaginalis and Female Infertility: A Meta-Analysis. Journal of Obstetrics, Gynecology and Cancer Research, 7(6), 513-517.

Hazlina, N. H. N., Norhayati, M. N., Bahari, I. S., & Arif, N. A. N. M. (2022). Worldwide prevalence, risk factors and psychological impact of infertility among women: a systematic review and meta-analysis. BMJ open, 12(3), e057132.

Henkel, R. (2020). Infection in infertility. Male Infertility: Contemporary Clinical Approaches, Andrology, ART and Antioxidants, 409-424.

Henkel, R., Offor, U., & Fisher, D. (2021). The role of infections and leukocytes in male infertility. Andrologia, 53(1), e13743.

Khalafalla, K., El Ansari, W., Sengupta, P., Majzoub, A., Elbardisi, H., Canguven, O., … & Arafa, M. (2023). Are sexually transmitted infections associated with male infertility? A systematic review and in-depth evaluation of the evidence and mechanisms of action of 11 pathogens. Arab Journal of Urology, 21(4), 216-232.

Kristensen, T. S., Foldager, A., Laursen, A. S. D., & Mikkelsen, E. M. (2025). Sexually transmitted infections (Chlamydia trachomatis, genital HSV, and HPV) and female fertility: A scoping review. Sexual & Reproductive Healthcare, 101067.

Mathias, B. A., Muñoz, T. I. C., Guaicha, E. P. G., Quinde, A. P. G., & Herrera, M. F. B. (2024). Side effects of Sexually Transmitted Infections (STIs) on female fertility: diagnostic and treatment strategies—a literature review. Ibero-American Journal of Health Science Research, 4(1), 84-92.

Mbah, C. E., Jasani, A., Aaron, K. J., Akoachere, J. F., Tita, A. T., Geisler, W. M., … & Ngeudia, J. C. A. (2022). Association between Chlamydia trachomatis, Neisseria gonorrhoea, Mycoplasma genitalium, and Trichomonas vaginalis and secondary infertility in Cameroon: A case-control study. Plos one, 17(2), e0263186.

Rajabpour, M., Emamie, A. D., Pourmand, M. R., Goodarzi, N. N., Asbagh, F. A., & Whiley, D. M. (2020). Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis among women with genitourinary infection and pregnancy-related complications in Tehran: A cross-sectional study. International Journal of STD & AIDS, 31(8), 773-780.

Tramontano, L., Sciorio, R., Bellaminutti, S., Esteves, S. C., & Petignat, P. (2023). Exploring the potential impact of human papillomavirus on infertility and assisted reproductive technology outcomes. Reproductive Biology, 23(2), 100753.

Zuo, Y., Jiang, T. T., Teng, Y., Han, Y., Yin, Y. P., & Chen, X. S. (2023). Associations of Chlamydia trachomatis serology with fertility-related and pregnancy adverse outcomes in women: a systematic review and meta-analysis of observational studies. EBioMedicine, 94.